India may have underestimated Beijing's resolve: Chinese media

April 5, 2017

Beijing, Apr 5: India is using the Dalai Lama as a diplomatic leverage to challenge China's "bottom line", Chinese state media said today, threatening that New Delhi may have "underestimated" Beijing's determination to protect its core interests.

indfia

The Chinese reaction to the Dalai Lama's visit to Tawang in Arunachal Pradesh came in an article in the state-run Global Times, which is part of the ruling Communist Party publications an is known for striking nationalistic postures.

"Beijing has voiced concerns over the issue, but New Delhi claimed that China shouldn't intervene in its 'internal affairs'," the article said, referring to Indian Minister of State for Home Affairs Kiren Rijiju's comments yesterday.

"Thisis absurd," the article said. Rijiju has said India never interfered in Beijing's affairs, has respected the "One China" policy, and thus China should not interfere in India's internal affairs or object to the Dalai Lama's visit. "There is no political angle behind his holiness's visit to Arunachal Pradesh. It is completely religious." Separately, External Affairs Ministry has said that no "artificial controversy" should be created about the visit.

The Chinese Foreign Ministry is yet to react to Rijiju's comments or the External Affairs statement yesterday. However, the state media asked India to "overcome its suspicion" of Beijing. "China doesn't allow India to free ride on its economic growth while jeopardising Beijing's core interests."

It warned, "New Delhi may have underestimated Beijing's determination to safeguard its core interests. Many countries have pledged not to extend invitations to the Dalai Lama. As the two largest emerging economies, China and India have great potential for cooperation."

Today's article also accused India of playing the "Tibet card" as it is dissatisfied with Beijing's stance on India's bid for Nuclear Suppliers Group membership and its attempts to add Masood Azhar, the chief of Pakistan-backed militant group Jaish-e-Mohammed (JeM), to a UN Security Council blacklist.

"Therefore, Delhi attempts to play the Tibet card against Beijing," it said, adding that "unlike his predecessors, India's Prime Minister Narendra Modi seems to have taken a different stance on the Dalai issue, raising public engagements with the monk and challenging Beijing's bottom line," it said.

India and China have had discussions on the two issues, yet the matters are far from being resolved, leading to strain in ties. Also, China is sensitive to the visit of the Dalai Lama, who it calls an "anti-China separatist", to Arunachal's Tawang region which happens to be the birthplace in 1683 of the sixth Dalai Lama and is at the centre of Tibetan Buddhism.

China has in recent days upped its rhetoric on claims to parts of Arunachal Pradesh, which it calls southern Tibet, and even warned India of "serious damage" to ties if New Delhi allowed Tibet's exiled spiritual leader's visit to go ahead.

The article added, "India is also exploring the option of linking the strategic border district of Tawang with a railway network, another provocation against Beijing. India has also invited a 'parliamentary delegation from Taiwan in February'."

Citing other instances like the Dalai Lama's meeting with President Pranab Mukherjee in December, which Beijing sees as a "provocation", it quoted Rijiju as having said to an international news agency in an interview that "it's a behavioural change you are seeing. India is more assertive."

It said that the Dalai Lama is "now openly used by India as a diplomatic tool to win more leverage." Last night, another piece on the newspaper's website said India was using the Dalai Lama's visit to Tawang "to upset" China.

An unnamed Chinese analyst told the newspaper that the 14th Dalai Lama's visit to Tawang will hurt Sino-Indian ties. "The Dalai's visit to the controversial area, especially Tawang, which China hopes will be returned, will affect relations between China and India," the analyst from the Institute of Asia-Pacific Studies of the Chinese Academy of Social Sciences told the paper on the condition of anonymity.

The analyst too pointed out the religious significance of the Tawang to Tibetans, saying it's the birthplace of the sixth Dalai Lama Tsangyang Gyatso. The analyst said this was not the first time India has used the Dalai Lama to express its displeasure to China, especially when bilateral talks fail to include their demands or to "pander to domestic anti-China issues".

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 7,2020

Jan 7: Body of the senior Iranian military commander, Qasem Soleimani killed in a U.S. drone strike in Iraq last week, has arrived in his home town of Kerman in southeast Iran for burial, the official IRNA news agency said on Tuesday.

State TV broadcast live images of thousands of people in the streets of the town, many of them dressed in black, to mourn Soleimani's death.

Soleimani was widely seen as Iran’s second most powerful figure behind Supreme Leader Ayatollah Ali Khamenei, 80, who wept in grief along with hundreds of thousands of mourners who thronged the streets of Tehran for Soleimani’s funeral on Monday.

Khamenei led prayers at the funeral in the Iranian capital, pausing as his voice cracked with emotion. Soleimani, 62, was a national hero even to many who do not consider themselves supporters of Iran’s clerical rulers.

He was killed while leaving Baghdad airport last Friday. Mourners packed the streets, chanting: “Death to America!” - a show of national unity after anti-government protests in November in which many demonstrators were killed.

The crowd, which state media said numbered in the millions, recalled the masses gathered in 1989 for the funeral of the Islamic Republic’s founder, Ayatollah Ruhollah Khomeini.

The killing of Soleimani has prompted fears around the world of a broader regional conflict, as well as calls in the U.S. Congress for legislation to keep President Donald Trump from going to war against Iran.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Melbourne, Apr 10: Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19.

The research, published in the journal Nature, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.

"Currently there are no targeted therapeutics or effective treatment options for COVID-19," said Professor Luke Guddat from the University of Queensland in Australia.

"In order to rapidly discover lead compounds for clinical use, we initiated a programme of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus," Guddat said.

The project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication, the researchers said.

This makes it an attractive drug target for this virus, and as people don't naturally have this enzyme, compounds that target it are likely to have low toxicity, they said.

"We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus. If the amount is small, then we have a promising compound for further studies," said Guddat.

After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.

"We're particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer," Guddat said.

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

"With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future," Guddat said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 4,2020

The death toll in China's coronavirus rose sharply to 425 with 64 deaths on Monday alone while 3,235 new confirmed cases were reported, taking the number of those infected with the deadly disease to 20,438, Chinese health authorities said on Tuesday.

The 64 people who died on Monday were all from the Hubei province, the epicentre of the virus, China's National Health Commission said.

Also, 3,235 new confirmed cases of novel coronavirus infection were reported, a big increase in a day.

Another 5,072 new suspected cases were reported on Monday, said the commission, adding that 492 patients became seriously ill.

The commission said that 2,788 patients remained in severe condition and 23,214 people were suspected of being infected with the virus, a pointer that it is increasingly turning virulent.

The overall confirmed cases on the Chinese mainland had reached 20,438 by the end of Monday, the commission said, noting that a total of 425 people had died of the disease.

A total of 632 people had been discharged from hospital after recovery, state-run Xinhua news agency reported As the virus spreads from human to human, 221,015 close contacts had been traced, with 171,329 others still under medical observation.

By the end of Monday, 15 confirmed cases had been reported in Hong Kong, eight in the Macao and 10 in Taiwan.

The Philippines reported the first overseas death from the virus on Sunday while 148 cases have been reported from abroad.

India has reported three cases of the coronavirus. All the three patients from Kerala recently returned from the affected Wuhan city.

Currently, 647 Indians and seven Maldivians who have been evacuated from Wuhan and Hubei are in 14-day quarantine at a medical camp in Manesar, near Delhi.

As the virus continued to spread at an alarming rate, Chinese President Xi Jinping on Monday warned officials of punishment if they shirked responsibility in tackling the virus outbreak.

On Monday, China has opened a 1,000-bed hospital built in record nine days in Wuhan city and started trials for new drug to contain the virus and is set to open another 1,300 bed hospital next to it on Wednesday.

The ruling Communist Party of China on Monday held its political bureau meeting presided by President Xi to review the steps being taken on various fronts to halt the spread of the deadly virus.

The outcome of the epidemic prevention and control directly affects people's lives and health, the overall economic and social stability and the country's opening-up, Xi said.

"Those who disobey the unified command or shirk off responsibilities will be punished," Xi was quoted as saying by the state-run Xinhua news agency.

Xi said that the party and government leaders supervising them would also be held accountable in severe cases.

Chinese armament firms, including those building aircraft carrier and military aircraft, have postponed planned work in order to concentrate on controlling the risk of coronavirus, state-run Global Times reported.

Noted Chinese health expert Zhong Nanshan has said that based on the fresh evidence, the novel coronavirus, which is spreading rapidly in China and the world, may reach its peak in the next 10 to 14 days, contrary to earlier estimates of climaxing sooner.

This means that the cases would drastically increase in the next two weeks before slowing down.

Also, China has begun clinical trials to test a drug to treat the patients of the coronavirus which till now has no cure.

Currently, patients are being treated with a combination of antivirals and other measures, as scientists race to find a vaccine.

Some reports said drugs to treat HIV too was being tried to treat the patients.

The experimental antiviral drug, Remdesivir, to be tested in field trials is developed by US-based Gilead Sciences. It is aimed at treating infectious diseases such as Ebola and SARS, South China Morning Post reported.

It was given to the first US patient last week - a 35-year-old man whose condition appeared to improve within a day, it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.